Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CDIO
CDIO | US
1.83
USD0.02
1.10%
CDIO | US
About CDIO
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
10/04/2026
Close
1.83
Open
1.88
High
1.88
Low
1.76
Cardio Diagnostics Holdings Inc. an artificial intelligence-powered precision cardiovascular medicine company develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events including heart attacks; and PrecisionCHD an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago Illinois.
View LessCDIO | US
Risk
158.9
Sharpe
-0.53
Luna's Score
43/100
Recommendation
Sell
Luna says (CDIO | US)
What's Working
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
112.5%1 month
158.9%3 months
256.3%6 months
198.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.10
Debt to equity
0.28
Debt to assets
0.22
Ent. to EBITDA
-22.48
Ent. to rev.
151.27
PEG
-
Other Fundamentals
EBITDA
-8.22M
MarketCap
56.00M
MarketCap(USD)
56.00M
Div. yield
-
Op. margin
-16.30K
Erngs. growth
-
Rev. growth
356.20
Ret. on equity
-293.27
Short ratio
1.55
Short perc.
13.77
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.57
Range1M
3.32
Range3M
6.94
Volumes: Market Activity
Rel. volume
0.24
Price X volume
116.78K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -22.48 | - | Cheaper |
| Ent. to Revenue | 151.27 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.10 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 256.30 | - | Riskier |
| Debt to Equity | 0.28 | -1.23 | Expensive |
| Debt to Assets | 0.22 | 0.25 | Par |
| Market Cap | 56.00M | - | Emerging |
